JT
TYRA icon

Jupiter Topco’s Tyra Biosciences TYRA Stock Holding History

Jupiter Topco’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$139M Buy
+4,352,448
New +$144M 0.06% 268

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jupiter Topco's TYRA Position: Q2 2026 in Review

Jupiter Topco opened a new position in Tyra Biosciences (TYRA) in Q2 2026: 4,352,448 shares worth $139M. The stake represents 0.06% of the portfolio and ranks #268 among its holdings.

155 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Jupiter Topco held 4,352,448 shares of Tyra Biosciences worth $139M as of Q2 2026.
  • Tyra Biosciences was a new Jupiter Topco position in Q2 2026.
  • Tyra Biosciences made up 0.06% of Jupiter Topco's portfolio in Q2 2026, its #268 holding.
  • 155 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.